Facilitating Over $2.5 Billion in Non-Dilutive Funding for Life Sciences Innovation.

The company specializes in providing exceptional consulting services within the life sciences sector, addressing intricate business, regulatory, and product development challenges for pharmaceutical, biotech, contract research organizations, academia, as well as medical device and diagnostic companies. It offers expertise across the entire product development lifecycle, supporting areas such as vaccines, therapeutics, cell and gene therapies, and medical devices. By leveraging a wealth of industry knowledge and an expansive network, the company can connect programs with fitting government opportunities and agencies, ensuring seamless navigation through complex processes. This depth of expertise, coupled with a strategic business model, empowers clients to make informed decisions and enhance the success of their products and programs.

With a foundation of seasoned professionals, each possessing over two decades of industry experience, the company is well-equipped to drive value creation for both emerging start-ups and global organizations. Having facilitated over $2.5 billion in non-dilutive funding and more than $100 million in licensing fees and investments, it is a trusted partner for managing pipeline reviews, conducting industry benchmarking, and prioritizing asset opportunities. Its capabilities extend to providing critical market research, due diligence, and financial modeling support, essential for achieving organizational objectives in the competitive life sciences arena. Through these comprehensive services, it delivers tailored development and funding solutions that meet specific client needs.